I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for ...

Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...

I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and ...

Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, ...

A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.

Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at specialized centers while enabling ongoing treatment closer to home for ...

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma, while expressing optimism about emerging therapies like CAR T cells ...

The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are ...

Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and ...